Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

In Vivo Optimization Study of the Braindex Cerebral Tissue Oxygen Saturation (SctO2) Measurement Algorithm Compared to a Mixed Reference Value of Jugular Venous and Systemic Arterial Saturation During Proven Cerebral Autoregulation Loss

NCT05897060 is registered in ClinicalTrials.gov with Braindex as lead sponsor.

NCT NCT05897060
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05897060 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
In Vivo Optimization Study of the Braindex Cerebral Tissue Oxygen Saturation (SctO2) Measurement Algorithm Compared to a Mixed Reference Value of Jugular Venous and Systemic Arterial Saturation During Proven Cerebral Autoregulation Loss
Lead sponsor
Braindex
Phase
Not applicable
Overall status
Unknown status
Start date
May 11, 2023
Completion date
October 30, 2023
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

post-operative confusion